Tag: biosimilar growth hormones market

  • Key Insights into the Biosimilar Growth Hormones Market’s Growth Opportunities for 2024-2033

    Key Insights into the Biosimilar Growth Hormones Market’s Growth Opportunities for 2024-2033

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    What is the Estimated Growth Rate for the Biosimilar Growth Hormones Market Between 2024 and 2033?

    In recent times, the biosimilar growth hormones market has seen substantial expansion. The market size is estimated to increase from $0.76 billion in 2023 to $0.82 billion in 2024, with a compound annual growth rate (CAGR) of 8.4%. Factors such as the escalating need for growth hormones, expiry of patents, clinical evidence, and the surge in clinical trials contributed to the significant growth during the historical period.

    The market size for biosimilar growth hormones is projected to robustly increase in the upcoming years, reaching $1.19 billion in 2028, with a compound annual growth rate (CAGR) of 9.8%. The expansion during the forecast period is due to factors such as growth disorders in children, widening indications, an uptick in diagnoses, and heightened awareness about biosimilar alternatives. The forecast period is expected to see significant trends like biosimilars targeted at children, combinations of biosimilars, and dosing convenience.

    Claim Your Free Sample of the Global Biosimilar Growth Hormones Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=3391&type=smp

    What Are the Primary Contributors to the Growth of the biosimilar growth hormones Market?

    The global biosimilar growth hormone market is expanding due to the escalating number of children dealing with growth hormone deficiency. Damage to the pituitary gland or hypothalamus, which may be congenital, as in an abnormal development that occurred before the baby’s birth, or acquired, as in something that happened during or after the delivery, typically causes the deficiency. Approximately 1 in 3,800 babies has been found to have this deficiency. Moreover, factors such as brain tumors, brain surgeries, radiation therapies, injuries, or infections may lead some children to acquire this deficiency later in their lives. Therefore, the rising number of children having growth defects propels the growth of the biosimilar growth hormones market.

    Which Key Segments Comprise the Biosimilar Growth Hormones Market?

    1) By Route Of Administration: Intravenous, Subcutaneous, Intramuscular, Oral

    2) By Application: Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature, Prader Willi Syndrome, Other Applications

    3) By Distribution Channel: Hospital And Retail Pharmacy, Online Pharmacy/ePharmacy, Specialty Clinics

    What Are the Key Trends Reshaping the Biosimilar Growth Hormones Market?

    The biosimilar growth hormone sector is increasingly turning to recombinant DNA technology (rDNA technology) for its advancement. The introduction of biosimilar growth hormone through the use of this technology is a notable emerging trend. For example, Pfizer Inc., a pharmaceutical company based in the United States, announced in February 2021 that it had begun a Phase III clinical trial to investigate the effectiveness and safety of somatropin in a group of Japanese individuals with Prader-Willi Syndrome (PWS). Somatropin, a growth hormone, is used to treat growth hormone deficiency (GHD) in children. This trial, however, is being conducted as a multi-cohort, open-label study across multiple centres.

    Order Now for Fast Delivery of Your Biosimilar Growth Hormones Market Report!

    https://www.thebusinessresearchcompany.com/report/biosimilar-growth-hormone-global-market-report

    What Are the Top Regions Fueling Growth in the Biosimilar Growth Hormones Market?

    North America was the largest region in the biosimilar growth hormone market in 2023. The Middle East is expected to be the fastest-growing region in the biosimilar growth hormones market report during the forecast period. The regions covered in the biosimilar growth hormones market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

    The Biosimilar Growth Hormones Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the biosimilar growth hormones market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Biosimilar Growth Hormones Market Include

    1. Biosimilar Growth Hormones Market Executive Summary

    2. Biosimilar Growth Hormones Market Segments

    3. Biosimilar Growth Hormones Market Size And Template Market Growth Rate

    4. Key Biosimilar Growth Hormones Market Trends

    5. Major Biosimilar Growth Hormones Market Drivers

    ……

    25. Key Mergers And Acquisitions In The Biosimilar Growth Hormones Market

    26. Top Biosimilar Growth Hormones Companies

    27. Biosimilar Growth Hormones Market Opportunities And Strategies

    28. Biosimilar Growth Hormones Market, Conclusions And Recommendations

    29. Appendix

    Discover Related Reports by The Business Research Company:

    Hormonal Contraceptives Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/hormonal-contraceptives-global-market-report

    Parathyroid Hormone Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/parathyroid-hormones-global-market-report

    Biosimilar Hormones Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/biosimilar-hormone-global-market-report

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Global Biosimilar Growth Hormones Market Report 2024 – Top Market Trends And Opportunities

    Global Biosimilar Growth Hormones Market Report 2024 – Top Market Trends And Opportunities

    The Business Research Company’s market reports offer an in-depth analysis on the market’s growth potential, major drivers, key trends and more.

    Market Expansion and Projections

    • The biosimilar growth hormones market has experienced significant growth in recent years.
    • From $0.76 billion in 2023, it is forecasted to reach $0.82 billion in 2024, boasting a CAGR of 8.4%.
    • Factors contributing to historic growth include rising demand, patent expirations, and clinical advancements.

    Forecasted Growth and Catalysts

    • Anticipated expansion to $1.19 billion by 2028, with a CAGR of 9.8%.
    • Drivers include pediatric growth disorders, expanded indications, and heightened awareness of biosimilar options.
    • Emerging trends focus on pediatric biosimilars, dosing convenience, and innovative combinations.

    Childhood Growth Hormone Deficiency Drives Market Demand

    • The rising incidence of childhood growth hormone deficiency propels market growth.
    • Causes include damage to the pituitary gland or hypothalamus, leading to congenital or acquired deficiency.
    • Identified in about 1 in every 3,800 babies, with various acquired causes later in life.

    Read More On The Biosimilar Growth Hormones Market Report 2024 – https://www.thebusinessresearchcompany.com/report/biosimilar-growth-hormone-global-market-report

    Technological Advancements in Production

    • Recombinant DNA technology (rDNA technology) transforms biosimilar growth hormone production.
    • Pfizer’s Phase III trial for somatropin in Prader-Willi Syndrome exemplifies rDNA technology’s application.
    • Advancements enhance affordability and efficacy of biosimilar growth hormones.

    Strategic Acquisition Reinforces Innovation

    • Amgen’s acquisition of Horizon Therapeutics for $27.8 billion enhances patient care and innovation.
    • Horizon’s portfolio includes medications addressing thyroid eye disease, chronic refractory gout, and neuromyelitis optica spectrum disorder.
    • Acquisition accelerates revenue growth and supports future innovation endeavors.

    Market Segmentation

    • Route of Administration: Intravenous, Subcutaneous, Intramuscular, Oral
    • Application: Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature, Prader Willi Syndrome, Other Applications
    • Distribution Channel: Hospital And Retail Pharmacy, Online Pharmacy/ePharmacy, Specialty Clinics

    Regional Dynamics

    • North America led the biosimilar growth hormones market in 2023.
    • The Middle East is poised to be the fastest-growing region during the forecast period.

    In conclusion, the biosimilar growth hormones market demonstrates significant growth potential driven by technological advancements, rising pediatric growth disorders, and strategic acquisitions. As recombinant DNA technology revolutionizes production processes, biosimilar growth hormones become more accessible and effective. Moreover, strategic acquisitions bolster innovation and patient care, signaling a dynamic landscape poised for expansion. The market’s segmentation and regional dynamics underscore its adaptability to diverse healthcare needs, promising improved treatment options for patients worldwide.

    Request for A Sample Of The Global Biosimilar Growth Hormones Market Report:
    https://www.thebusinessresearchcompany.com/sample_request?id=3391&type=smp